Cardinal Health (NYSE:CAH) Price Target Raised to $145.00

Cardinal Health (NYSE:CAH) had its price objective hoisted by JPMorgan Chase & Co. from $142.00 to $145.00 in a report issued on Tuesday morning,Benzinga reports. They currently have a neutral rating on the stock.

CAH has been the subject of a number of other reports. Barclays raised their price objective on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective for the company in a research report on Tuesday, January 7th. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Finally, Wells Fargo & Company raised their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Four research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $136.87.

Cardinal Health Stock Down 0.3 %

NYSE CAH opened at $127.07 on Tuesday. Cardinal Health has a 52 week low of $93.17 and a 52 week high of $132.84. The business’s fifty day simple moving average is $122.35 and its 200-day simple moving average is $114.92. The firm has a market cap of $30.70 billion, a PE ratio of 23.71, a P/E/G ratio of 1.46 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Research analysts expect that Cardinal Health will post 7.92 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s payout ratio is presently 37.69%.

Hedge Funds Weigh In On Cardinal Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Eastern Bank purchased a new position in shares of Cardinal Health in the 3rd quarter valued at about $25,000. Frazier Financial Advisors LLC boosted its stake in shares of Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after buying an additional 104 shares during the period. Promus Capital LLC purchased a new position in shares of Cardinal Health in the 4th quarter valued at about $30,000. Hara Capital LLC purchased a new position in shares of Cardinal Health in the 3rd quarter valued at about $31,000. Finally, AM Squared Ltd purchased a new position in shares of Cardinal Health in the 3rd quarter valued at about $33,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.